FDA bans sale of Bextra joint ache painkiller

The Food and Drug Administration has followed the US FDA's lead by banning the sale of Bextra, a kind of painkiller for joint aches which puts users at risk of heart attack and skin conditions.

The US FDA on April 7 asked Pfizer to withdraw Bextra from the market and announced actions to be taken regarding the marketing of NSAIDs (non-steroidal anti-inflammatory drugs).